Rubana Kalyani Email & Phone Number | 25 years of biopharmaceutical industry experience in pre-clinical R&D, clinical operations, and clinical development. Clinical experience with drug products in early and late-stage development in a broad range of therapeutic areas including infectious disease/vaccines (pneumonia, influenza, anti-bacterial), oncology (solid tumors, glioblastoma, hepatocellular, colorectal), renal/metabolic (diabetes, anti-obesity, hyperphosphatemia), respiratory (asthma), and immunology (allergy, rheumatoid arthritis, osteoarthritis/acute pain, systemic lupus erythematosus, cutaneous lupus erythematosus, systemic sclerosis).

Rubana Kalyani

25 years of biopharmaceutical industry experience in pre-clinical R&D, clinical operations, and clin...
Gaithersburg, Maryland, United States

*50 free lookup(s) per month.

Rubana Kalyani’s Phone Numbers

Get RUBANA’s Phone Number (For Free)

Social Media

Rubana Kalyani’s Location Gaithersburg, Maryland, United States

Rubana Kalyani’s Current Industry Astrazeneca

Rubana Kalyani’s Prior Industry Clinikal Resources | Merck

Find accurate emails & phone numbers for over 700M professionals.

Global Clinical Program Lead

2023-04-01 00:00:00 - Present

Independent Clinical Research Consultant

2011-10-01 00:00:00 - 2014-12-01 00:00:00

Medical Program Coordinator

2000-01-01 00:00:00 - 2001-02-01 00:00:00

No Skills Available

No Languages Available

Rubana Kalyani is a 25 years of biopharmaceutical industry experience in pre-clinical R&D, clinical operations, and clinical development. Clinical experience with drug products in early and late-stage development in a broad range of therapeutic areas including infectious disease/vaccines (pneumonia, influenza, anti-bacterial), oncology (solid tumors, glioblastoma, hepatocellular, colorectal), renal/metabolic (diabetes, anti-obesity, hyperphosphatemia), respiratory (asthma), and immunology (allergy, rheumatoid arthritis, osteoarthritis/acute pain, systemic lupus erythematosus, cutaneous lupus erythematosus, systemic sclerosis).